<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Company Performance on FinanClub</title>
    <link>https://finan.club/tags/company-performance/</link>
    <description>Recent content in Company Performance on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 25 Dec 2023 09:02:07 +0000</lastBuildDate><atom:link href="https://finan.club/tags/company-performance/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>TGTX</title>
      <link>https://finan.club/us/tgtx/</link>
      <pubDate>Mon, 25 Dec 2023 09:02:07 +0000</pubDate>
      
      <guid>https://finan.club/us/tgtx/</guid>
      <description>score:77
Chances: TG Therapeutics stock has seen a welcome improvement in its Relative Strength Rating, indicating positive market activity. The average of price targets set by Wall Street analysts indicates a potential upside of 127.8% in TG Therapeutics, pointing towards a positive trend in earnings estimate revisions.</description>
    </item>
    
  </channel>
</rss>
